Description
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Cas No. | 1096708-71-2 |
|---|---|
| Purity | ≥98% |
| Formula | C17H12Cl2F3N7O2S |
| Formula Wt. | 506.30 |
| IUPAC Name | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5- chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
| Solubility | DMSO 100 mg/mL (197.51 mM) Ethanol 100 mg/mL (197.51 mM) Water Insoluble |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
http://clinicaltrials.gov/show/NCT01425008
Selective inhibitor of cytochrome P450 1B1 (CYP...
LRRK2 inhibitor.
Endogenous peptide, involved in paracrine and a...
β-adrenergic antagonist, Kv1.4 and K2P2 K+ cha...
Taxol synthesis intermediate.
NSAID; COX-1/2 and lactate dehydrogenase inhibi...
HDAC6/10 inhibitor.
Non-endogenous essential amino acid found in me...
Peptide, binds heparin.
Pt-based DNA cross-linker.
p110α PI3K and mTOR inhibitor.
5-HT1A partial agonist, 5-HT2, histamine, α1/2...
Recombinant Multi-epitope Chimeric HCV antigen....
Phthalide; PPARγ agonist, IMPDH inhibitor, mic...
Prodrug
α7 and β4 nAChR agonist, α4β2 and α6β2 nA...
Peptide, GLP-1 analog found in Heloderma; GLP-1...
Cannabinoid receptor 2 selective agonist.
EphB4 inhibitor.
CHK1 inhibitor.